Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
15 dec 2006 - 14:05
Statutaire naam
Crucell N.V.
Titel
Crucell Reports First Orders For Contract Manufacturing Agreement with Wyeth Biotech
Bericht
Leiden, The Netherlands, December 15, 2006 – Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced it has received its first orders for the CMO agreement with New Jersey-headquartered Wyeth Biotech. The CMO agreement for formulation and filing of a vaccine was finalized end 2005 and will have the first business impact for Crucell in 2007.
Datum laatste update: 08 oktober 2024